Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact Us
Search
Close
Enter Search Terms
Search
Allyson Whyte Nowak
ID:
1b839958-2619-30fb-68c4
/
Claimed Record
/
Organization:
Norton Rose Fulbright
Published Works
35 articles
Ontario Superior Court denies pleading amendments based on Supreme Court of Canada’s rejection of promise doctrine in ramipril damages action
Pharma in Brief ·
February 15, 2018
cite
FCA upholds damage award based on Teva’s infringing sales of levofloxacin
Pharma in Brief ·
February 14, 2018
cite
Federal Court releases new guidelines for prohibition actions under the amended Patented Medicines (Notice of Compliance) Regulations
Pharma in Brief ·
September 27, 2017
cite
CETA tracker: CETA implemented September 21
Pharma in Brief ·
September 20, 2017
cite
Apotex disentitled to section 8 recovery on the basis of patent infringement in omeprazole case
Pharma in Brief ·
September 17, 2017
cite
Previous
1
...
5
6
7
Next
Practice Areas
Health Care and Life Sciences
Intellectual Property
Jurisdictions
Canada
North America
United States